TNAM
TMO icon

Terra Nova Asset Management’s Thermo Fisher Scientific TMO Stock Holding History

Terra Nova Asset Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-528
Closed -$214K – 97
2025
Q2 		$214K Sell
528
-266
-34% -$111K 0.15% 86
2025
Q1 		$395K Sell
794
-47
-6% -$25.5K 0.31% 62
2024
Q4 		$438K Sell
841
-2,211
-72% -$1.22M 0.33% 64
2024
Q3 		$1.89M Sell
3,052
-251
-8% -$149K 1.4% 33
2024
Q2 		$1.83M Sell
3,303
-19
-0.6% -$10.9K 1.44% 30
2024
Q1 		$1.93M Buy
3,322
+1
+0% +$561 1.54% 32
2023
Q4 		$1.76M Sell
3,321
-567
-15% -$274K 1.55% 29
2023
Q3 		$2.03M Hold
3,888
– – 1.85% 20
2023
Q2 		$2.03M Buy
3,888
+12
+0.3% +$6.48K 1.85% 20
2023
Q1 		$2.23M Sell
3,876
-48
-1% -$27.1K 2.19% 13
2022
Q4 		$2.16M Sell
3,924
-194
-5% -$103K 2.27% 8
2022
Q3 		$2.09M Buy
4,118
+75
+2% +$42K 2.28% 12
2022
Q2 		$2.2M Sell
4,043
-105
-3% -$57.8K 2.44% 11
2022
Q1 		$2.45M Sell
4,148
-1,033
-20% -$593K 2.28% 14
2021
Q4 		$3.46M Buy
5,181
+64
+1% +$40K 2.59% 8
2021
Q3 		$2.92M Buy
5,117
+191
+4% +$105K 2.35% 10
2021
Q2 		$2.48M Sell
4,926
-296
-6% -$140K 2.13% 14
2021
Q1 		$2.38M Sell
5,222
-627
-11% -$299K 2.11% 14
2020
Q4 		$2.72M Buy
+5,849
New +$2.74M 2.75% 12
2018
Q4 		$1.15M Sell
5,140
-973
-16% -$228K 3.1% 14
2018
Q3 		$1.49M Hold
6,113
– – 2.26% 18
2018
Q2 		$1.27M Buy
6,113
+399
+7% +$84.7K 2.19% 21
2018
Q1 		$1.18M Buy
5,714
+140
+3% +$29.4K 2.09% 22
2017
Q4 		$1.06M Buy
5,574
+748
+15% +$143K 1.84% 27
2017
Q3 		$913K Buy
4,826
+55
+1% +$9.96K 1.87% 27
2017
Q2 		$832K Buy
4,771
+131
+3% +$22K 1.58% 30
2017
Q1 		$713K Buy
+4,640
New +$709K 1.43% 36

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Terra Nova Asset Management's TMO Position: Q3 2025 in Review

Terra Nova Asset Management sold out of Thermo Fisher Scientific (TMO) in Q3 2025, closing a stake of 528 shares — an estimated $214K sold.

Terra Nova Asset Management first reported a position in TMO in Q1 2017 and held it in 27 quarters. The position peaked at $3.46M in Q4 2021. 2,508 funds tracked by Wall St. Rank hold TMO as of Q3 2025.

  • Terra Nova Asset Management reported no remaining Thermo Fisher Scientific position as of Q3 2025 after selling out during the quarter.
  • Terra Nova Asset Management sold 528 Thermo Fisher Scientific shares in Q3 2025, an estimated $214K.
  • Terra Nova Asset Management first reported a position in Thermo Fisher Scientific in Q1 2017 and held it in 27 quarters.
  • Terra Nova Asset Management's Thermo Fisher Scientific position peaked at $3.46M in Q4 2021.
  • 2,508 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2025.

Based on Terra Nova Asset Management's 13F filing for Q3 2025, filed 14 Nov 2025.